Report Detail
Global and United States Viral and Non-Viral Vector Manufacturing Market Report & Forecast 2022-2028
- RnM4385594 |
- 21 February, 2022 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Summary:
Market Analysis and Insights: Global and United States Viral and Non-Viral Vector Manufacturing Market
This report focuses on global and United States Viral and Non-Viral Vector Manufacturing market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Viral and Non-Viral Vector Manufacturing market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Viral Vectors accounting for % of the Viral and Non-Viral Vector Manufacturing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Gene Therapy was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Viral and Non-Viral Vector Manufacturing market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Viral and Non-Viral Vector Manufacturing Scope and Market Size
Viral and Non-Viral Vector Manufacturing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Viral and Non-Viral Vector Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Viral and Non-Viral Vector Manufacturing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Viral and Non-Viral Vector Manufacturing market is segmented into
Viral Vectors
Non-Viral Vectors
Segment by Application, the Viral and Non-Viral Vector Manufacturing market is segmented into
Gene Therapy
Vaccinology
Cell Therapy
Others
Regional and Country-level Analysis
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Viral and Non-Viral Vector Manufacturing Market Share Analysis
Viral and Non-Viral Vector Manufacturing market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Viral and Non-Viral Vector Manufacturing business, the date to enter into the Viral and Non-Viral Vector Manufacturing market, Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
The major vendors covered:
Boehringer Ingelheim
Catalent, Inc.
FUJIFILM Holdings Corporation
Danaher Corporation
Genscript Biotech Corporation
Lonza Group AG
Merck KGaA Inc.
Oxford Biomedica Plc
Sartorius AG
Takara Bio Inc.
Thermo Fisher Scientific Inc.
Wuxi AppTec
Acuitas Therapeutics
Evonik Industries AG
Exelead, Inc.
Entos Pharmaceuticals
Genevant Sciences GmbH
T&T Scientific Corporation
Moderna, Inc.
CureVac N.V.
Table of Contents
1 Study Coverage
- 1.1 Viral and Non-Viral Vector Manufacturing Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million) Introduction
- 1.2 Global Viral and Non-Viral Vector Manufacturing Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global Viral and Non-Viral Vector Manufacturing Market Size for the Year 2017-2028
- 1.2.2 Global Viral and Non-Viral Vector Manufacturing Market Size for the Year 2017-2028
- 1.3 Viral and Non-Viral Vector Manufacturing Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.3.1 The Market Share of United States Viral and Non-Viral Vector Manufacturing in Global, 2017 VS 2022 VS 2028
- 1.3.2 The Growth Rate of Viral and Non-Viral Vector Manufacturing Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.4 Viral and Non-Viral Vector Manufacturing Market Dynamics
- 1.4.1 Viral and Non-Viral Vector Manufacturing Industry Trends
- 1.4.2 Viral and Non-Viral Vector Manufacturing Market Drivers
- 1.4.3 Viral and Non-Viral Vector Manufacturing Market Challenges
- 1.4.4 Viral and Non-Viral Vector Manufacturing Market Restraints
- 1.5 Study Objectives
- 1.6 Years Considered
2 Viral and Non-Viral Vector Manufacturing by Type
- 2.1 Viral and Non-Viral Vector Manufacturing Market Segment by Type
- 2.1.1 Viral Vectors
- 2.1.2 Non-Viral Vectors
- 2.2 Global Viral and Non-Viral Vector Manufacturing Market Size by Type (2017, 2022 & 2028)
- 2.3 Global Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2028)
- 2.4 United States Viral and Non-Viral Vector Manufacturing Market Size by Type (2017, 2022 & 2028)
- 2.5 United States Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2028)
3 Viral and Non-Viral Vector Manufacturing by Application
- 3.1 Viral and Non-Viral Vector Manufacturing Market Segment by Application
- 3.1.1 Gene Therapy
- 3.1.2 Vaccinology
- 3.1.3 Cell Therapy
- 3.1.4 Others
- 3.2 Global Viral and Non-Viral Vector Manufacturing Market Size by Application (2017, 2022 & 2028)
- 3.3 Global Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2028)
- 3.4 United States Viral and Non-Viral Vector Manufacturing Market Size by Application (2017, 2022 & 2028)
- 3.5 United States Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2028)
4 Global Viral and Non-Viral Vector Manufacturing Competitor Landscape by Company
- 4.1 Global Viral and Non-Viral Vector Manufacturing Market Size by Company
- 4.1.1 Top Global Viral and Non-Viral Vector Manufacturing Companies Ranked by Revenue (2021)
- 4.1.2 Global Viral and Non-Viral Vector Manufacturing Revenue by Player (2017-2022)
- 4.2 Global Viral and Non-Viral Vector Manufacturing Concentration Ratio (CR)
- 4.2.1 Viral and Non-Viral Vector Manufacturing Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Companies of Viral and Non-Viral Vector Manufacturing in 2021
- 4.2.3 Global Viral and Non-Viral Vector Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global Viral and Non-Viral Vector Manufacturing Headquarters, Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million) Type
- 4.3.1 Global Viral and Non-Viral Vector Manufacturing Headquarters and Area Served
- 4.3.2 Global Viral and Non-Viral Vector Manufacturing Companies Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million) Type
- 4.3.3 Date of International Companies Enter into Viral and Non-Viral Vector Manufacturing Market
- 4.4 Companies Mergers & Acquisitions, Expansion Plans
- 4.5 United States Viral and Non-Viral Vector Manufacturing Market Size by Company
- 4.5.1 Top Viral and Non-Viral Vector Manufacturing Players in United States, Ranked by Revenue (2021)
- 4.5.2 United States Viral and Non-Viral Vector Manufacturing Revenue by Players (2020, 2021 & 2022)
5 Global Viral and Non-Viral Vector Manufacturing Market Size by Region
- 5.1 Global Viral and Non-Viral Vector Manufacturing Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global Viral and Non-Viral Vector Manufacturing Market Size by Region (2017-2028)
- 5.2.1 Global Viral and Non-Viral Vector Manufacturing Market Size by Region: 2017-2022
- 5.2.2 Global Viral and Non-Viral Vector Manufacturing Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America Viral and Non-Viral Vector Manufacturing Market Size YoY Growth 2017-2028
- 6.1.2 North America Viral and Non-Viral Vector Manufacturing Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 United States
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific Viral and Non-Viral Vector Manufacturing Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific Viral and Non-Viral Vector Manufacturing Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 India
- 6.2.7 Australia
- 6.2.8 China Taiwan
- 6.2.9 Indonesia
- 6.2.10 Thailand
- 6.2.11 Malaysia
- 6.3 Europe
- 6.3.1 Europe Viral and Non-Viral Vector Manufacturing Market Size YoY Growth 2017-2028
- 6.3.2 Europe Viral and Non-Viral Vector Manufacturing Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America Viral and Non-Viral Vector Manufacturing Market Size YoY Growth 2017-2028
- 6.4.2 Latin America Viral and Non-Viral Vector Manufacturing Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Mexico
- 6.4.4 Brazil
- 6.4.5 Argentina
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa Viral and Non-Viral Vector Manufacturing Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa Viral and Non-Viral Vector Manufacturing Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 Turkey
- 6.5.4 Saudi Arabia
- 6.5.5 UAE
7 Company Profiles
- 7.1 Boehringer Ingelheim
- 7.1.1 Boehringer Ingelheim Company Details
- 7.1.2 Boehringer Ingelheim Business Overview
- 7.1.3 Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Introduction
- 7.1.4 Boehringer Ingelheim Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.1.5 Boehringer Ingelheim Recent Development
- 7.2 Catalent, Inc.
- 7.2.1 Catalent, Inc. Company Details
- 7.2.2 Catalent, Inc. Business Overview
- 7.2.3 Catalent, Inc. Viral and Non-Viral Vector Manufacturing Introduction
- 7.2.4 Catalent, Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.2.5 Catalent, Inc. Recent Development
- 7.3 FUJIFILM Holdings Corporation
- 7.3.1 FUJIFILM Holdings Corporation Company Details
- 7.3.2 FUJIFILM Holdings Corporation Business Overview
- 7.3.3 FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Introduction
- 7.3.4 FUJIFILM Holdings Corporation Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.3.5 FUJIFILM Holdings Corporation Recent Development
- 7.4 Danaher Corporation
- 7.4.1 Danaher Corporation Company Details
- 7.4.2 Danaher Corporation Business Overview
- 7.4.3 Danaher Corporation Viral and Non-Viral Vector Manufacturing Introduction
- 7.4.4 Danaher Corporation Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.4.5 Danaher Corporation Recent Development
- 7.5 Genscript Biotech Corporation
- 7.5.1 Genscript Biotech Corporation Company Details
- 7.5.2 Genscript Biotech Corporation Business Overview
- 7.5.3 Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Introduction
- 7.5.4 Genscript Biotech Corporation Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.5.5 Genscript Biotech Corporation Recent Development
- 7.6 Lonza Group AG
- 7.6.1 Lonza Group AG Company Details
- 7.6.2 Lonza Group AG Business Overview
- 7.6.3 Lonza Group AG Viral and Non-Viral Vector Manufacturing Introduction
- 7.6.4 Lonza Group AG Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.6.5 Lonza Group AG Recent Development
- 7.7 Merck KGaA Inc.
- 7.7.1 Merck KGaA Inc. Company Details
- 7.7.2 Merck KGaA Inc. Business Overview
- 7.7.3 Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Introduction
- 7.7.4 Merck KGaA Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.7.5 Merck KGaA Inc. Recent Development
- 7.8 Oxford Biomedica Plc
- 7.8.1 Oxford Biomedica Plc Company Details
- 7.8.2 Oxford Biomedica Plc Business Overview
- 7.8.3 Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Introduction
- 7.8.4 Oxford Biomedica Plc Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.8.5 Oxford Biomedica Plc Recent Development
- 7.9 Sartorius AG
- 7.9.1 Sartorius AG Company Details
- 7.9.2 Sartorius AG Business Overview
- 7.9.3 Sartorius AG Viral and Non-Viral Vector Manufacturing Introduction
- 7.9.4 Sartorius AG Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.9.5 Sartorius AG Recent Development
- 7.10 Takara Bio Inc.
- 7.10.1 Takara Bio Inc. Company Details
- 7.10.2 Takara Bio Inc. Business Overview
- 7.10.3 Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Introduction
- 7.10.4 Takara Bio Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.10.5 Takara Bio Inc. Recent Development
- 7.11 Thermo Fisher Scientific Inc.
- 7.11.1 Thermo Fisher Scientific Inc. Company Details
- 7.11.2 Thermo Fisher Scientific Inc. Business Overview
- 7.11.3 Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Introduction
- 7.11.4 Thermo Fisher Scientific Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.11.5 Thermo Fisher Scientific Inc. Recent Development
- 7.12 Wuxi AppTec
- 7.12.1 Wuxi AppTec Company Details
- 7.12.2 Wuxi AppTec Business Overview
- 7.12.3 Wuxi AppTec Viral and Non-Viral Vector Manufacturing Introduction
- 7.12.4 Wuxi AppTec Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.12.5 Wuxi AppTec Recent Development
- 7.13 Acuitas Therapeutics
- 7.13.1 Acuitas Therapeutics Company Details
- 7.13.2 Acuitas Therapeutics Business Overview
- 7.13.3 Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Introduction
- 7.13.4 Acuitas Therapeutics Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.13.5 Acuitas Therapeutics Recent Development
- 7.14 Evonik Industries AG
- 7.14.1 Evonik Industries AG Company Details
- 7.14.2 Evonik Industries AG Business Overview
- 7.14.3 Evonik Industries AG Viral and Non-Viral Vector Manufacturing Introduction
- 7.14.4 Evonik Industries AG Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.14.5 Evonik Industries AG Recent Development
- 7.15 Exelead, Inc.
- 7.15.1 Exelead, Inc. Company Details
- 7.15.2 Exelead, Inc. Business Overview
- 7.15.3 Exelead, Inc. Viral and Non-Viral Vector Manufacturing Introduction
- 7.15.4 Exelead, Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.15.5 Exelead, Inc. Recent Development
- 7.16 Entos Pharmaceuticals
- 7.16.1 Entos Pharmaceuticals Company Details
- 7.16.2 Entos Pharmaceuticals Business Overview
- 7.16.3 Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Introduction
- 7.16.4 Entos Pharmaceuticals Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.16.5 Entos Pharmaceuticals Recent Development
- 7.17 Genevant Sciences GmbH
- 7.17.1 Genevant Sciences GmbH Company Details
- 7.17.2 Genevant Sciences GmbH Business Overview
- 7.17.3 Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Introduction
- 7.17.4 Genevant Sciences GmbH Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.17.5 Genevant Sciences GmbH Recent Development
- 7.18 T&T Scientific Corporation
- 7.18.1 T&T Scientific Corporation Company Details
- 7.18.2 T&T Scientific Corporation Business Overview
- 7.18.3 T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Introduction
- 7.18.4 T&T Scientific Corporation Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.18.5 T&T Scientific Corporation Recent Development
- 7.19 Moderna, Inc.
- 7.19.1 Moderna, Inc. Company Details
- 7.19.2 Moderna, Inc. Business Overview
- 7.19.3 Moderna, Inc. Viral and Non-Viral Vector Manufacturing Introduction
- 7.19.4 Moderna, Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.19.5 Moderna, Inc. Recent Development
- 7.20 CureVac N.V.
- 7.20.1 CureVac N.V. Company Details
- 7.20.2 CureVac N.V. Business Overview
- 7.20.3 CureVac N.V. Viral and Non-Viral Vector Manufacturing Introduction
- 7.20.4 CureVac N.V. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
- 7.20.5 CureVac N.V. Recent Development
8 Research Findings and Conclusion
9 Appendix
- 9.1 Research Methodology
- 9.1.1 Methodology/Research Approach
- 9.1.2 Data Source
- 9.2 Author Details
Summary:
Get latest Market Research Reports on Viral and Non-Viral Vector Manufacturing. Industry analysis & Market Report on Viral and Non-Viral Vector Manufacturing is a syndicated market report, published as Global and United States Viral and Non-Viral Vector Manufacturing Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Viral and Non-Viral Vector Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
